Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in an Intermediate Risk Patient Population

NCT01972867 is registered in ClinicalTrials.gov with Angiodynamics, Inc. as lead sponsor.

NCT NCT01972867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01972867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study in Human Subjects Evaluating the Use of the NanoKnife System for Ablation of Prostate Cancer Tissue in an Intermediate Risk Patient Population
Lead sponsor
Angiodynamics, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
May 13, 2021
Completion date
May 31, 2024
Enrollment
6 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer